awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734
Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.
P2860
Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
305662bb23893868b2d47dd949d7f62c35d8f7b2
P2860
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.